BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kluska A, Balabas A, Piatkowska M, Czarny K, Paczkowska K, Nowakowska D, Mikula M, Ostrowski J. PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland. BMC Med Genomics 2017;10:14. [PMID: 28279176 DOI: 10.1186/s12920-017-0251-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Samtani R, Sharma N, Garg D. Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review. Reprod Sci 2018;25:7-18. [PMID: 28602118 DOI: 10.1177/1933719117711261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Kwong A, Shin VY, Ho CYS, Khalid A, Au CH, Chan KKL, Ngan HYS, Chan TL, Ma ESK. Germline PALB2 Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients. Cancers (Basel) 2021;13:4195. [PMID: 34439348 DOI: 10.3390/cancers13164195] [Reference Citation Analysis]
3 Rashid MU, Khan FA, Muhammad N, Loya A, Hamann U. Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan. Cancer Res Treat 2019;51:992-1000. [PMID: 30309218 DOI: 10.4143/crt.2018.356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Szczerba E, Kamińska K, Mierzwa T, Misiek M, Kowalewski J, Lewandowska MA. BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing. Genes (Basel) 2021;12:519. [PMID: 33918338 DOI: 10.3390/genes12040519] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ding Y, Wang C, Li X, Jiang Y, Mei P, Huang W, Song G, Wang J, Ping G, Hu R, Miao C, He X, Chen G, Li H, Zhu Y, Zhang Z. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases. Diagn Pathol 2018;13:54. [PMID: 30111351 DOI: 10.1186/s13000-018-0732-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
6 Preobrazhenskaya EV, Shleykina AU, Gorustovich OA, Martianov AS, Bizin IV, Anisimova EI, Sokolova TN, Chuinyshena SA, Kuligina ES, Togo AV, Belyaev AM, Ivantsov AO, Sokolenko AP, Imyanitov EN. Frequency and molecular characteristics of PALB2-associated cancers in Russian patients. Int J Cancer 2021;148:203-10. [PMID: 32997802 DOI: 10.1002/ijc.33317] [Reference Citation Analysis]
7 Campbell-Salome G, Rauscher EA. Family storytelling about hereditary cancer: Framing shared understandings of risk. J Genet Couns 2020;29:936-48. [PMID: 31970844 DOI: 10.1002/jgc4.1218] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Velázquez C, Esteban-Cardeñosa EM, Lastra E, Abella LE, de la Cruz V, Lobatón CD, Durán M, Infante M. A PALB2 truncating mutation: Implication in cancer prevention and therapy of Hereditary Breast and Ovarian Cancer. Breast 2019;43:91-6. [PMID: 30521987 DOI: 10.1016/j.breast.2018.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Viakhireva I, Musatova E, Bessonova L, Shcherbatyuk Y, Korobkov S, Zhikriveckaya S, Sofronova Y, Mironova I, Khmelkova D, Konovalov F, Baranova A, Pomerantseva E, Skoblov M. Novel intronic variant in PALB2 gene and effective prevention of Fanconi anemia in family. Fam Cancer 2020;19:241-6. [PMID: 32052252 DOI: 10.1007/s10689-020-00165-6] [Reference Citation Analysis]
10 Yoo J, Lee GD, Kim JH, Lee SN, Chae H, Han E, Kim Y, Kim M. Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome. Ann Lab Med 2020;40:148-54. [PMID: 31650731 DOI: 10.3343/alm.2020.40.2.148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
11 Tomasova K, Cumova A, Seborova K, Horak J, Koucka K, Vodickova L, Vaclavikova R, Vodicka P. DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome. Cancers (Basel) 2020;12:E1713. [PMID: 32605254 DOI: 10.3390/cancers12071713] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]